Clinical trial
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
NCT00030901 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00030901 |
|---|---|
| Title | S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate |
| Official title | L-Selenium-Based Chemoprevention Of Prostate Cancer Among Men With High Grade Prostatic Intraepithelial Neoplasia |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Precancerous/Nonmalignant Condition, Prostate Cancer |
| Intervention type | Drug |
| Interventions | L-selenomethionine, L-selenomethionine placebo |
| Enrollment | 619 |
| Start date | Feb 1, 2000 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 6, 2013 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: